Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation

We analyzed potential biomarkers of response to ibrutinib plus nivolumab in biopsies from patients with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and Richter's transformation (RT) from the LYM1002 phase I/IIa study, using programmed death ligand 1 (PD-L1) immunohistochemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodkinson, Brendan P., Schaffer, Michael, Brody, Joshua D., Jurczak, Wojciech, Carpio, Cecilia, Ben-Yehuda, Dina, Avivi, Irit, Forslund, Ann, Özcan, Muhit, Alvarez, John, Ceulemans, Rob, Fourneau, Nele, Younes, Anas, Balasubramanian, Sriram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2020
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723809/
https://www.ncbi.nlm.nih.gov/pubmed/33395752
http://dx.doi.org/10.1016/j.tranon.2020.100977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723809/
https://www.ncbi.nlm.nih.gov/pubmed/33395752
http://dx.doi.org/10.1016/j.tranon.2020.100977

Ejemplares similares